Overview of Clindamycin-Benzoyl Peroxide
Clindamycin-Benzoyl Peroxide is a topical gel used to treat acne and other skin conditions. It combines the antibacterial properties of clindamycin with the drying and peeling effects of benzoyl peroxide. This medication is available under various brand names and generic formulations, with the NDC 45802-0507 being one of the identifiers for a specific product[4].
Current Pricing
As of the latest data available, the price per unit for Clindamycin-Benzoyl Peroxide 1-5% with the NDC 45802-0507 is approximately $0.48506 per gram. This pricing is consistent across several manufacturers and distributors, indicating a stable market price for this specific formulation[1].
Market Trends
Drug Price Inflation
The pharmaceutical market is experiencing ongoing price inflation. According to Vizient's summer 2024 Pharmacy Market Outlook, the overall drug price inflation rate for pharmaceuticals is projected to be 3.81% for 2025. While this projection is more general and not specific to Clindamycin-Benzoyl Peroxide, it indicates a broader trend of increasing drug prices[3].
Generic Drug Price Increases
The Oregon Drug Price Transparency Program reported that generic drugs have seen significant price increases, with a median price increase of 19.9% in 2022. Although this data is not specific to Clindamycin-Benzoyl Peroxide, it suggests that generic drugs, including those in the dermatological category, could be subject to similar price fluctuations[2].
Factors Influencing Pricing
Supply Chain and Regulatory Oversight
The price of prescription drugs, including Clindamycin-Benzoyl Peroxide, is influenced by various factors within the pharmaceutical supply chain. These include interactions between manufacturers, pharmacy benefit managers (PBMs), health insurers, and regulatory bodies. In Oregon, for example, manufacturers are required to report price increases and new high-cost drugs, and PBMs must register and follow state laws, which can impact pricing transparency and stability[2].
Rebates and Discounts
Rebates and discounts also play a significant role in the final cost of prescription drugs. Health insurers often receive rebates from manufacturers, which can range from 5% to 21% of total pharmaceutical spending. These rebates can affect the net price paid by consumers and insurers but may not always be transparent[2].
Price Projections
Short-Term Projections
Given the current stable pricing and the general trend of drug price inflation, it is likely that the price of Clindamycin-Benzoyl Peroxide with NDC 45802-0507 will remain relatively stable in the short term, possibly increasing by a small margin consistent with the overall inflation rate.
Long-Term Projections
In the long term, several factors could influence the price:
- Inflation: As projected by Vizient, a continued inflation rate of around 3.81% could lead to gradual price increases.
- Market Competition: The presence of multiple manufacturers and generic versions could help maintain competitive pricing.
- Regulatory Changes: Any changes in regulatory oversight or transparency requirements could impact pricing strategies and rebates, potentially affecting the final cost to consumers.
Impact on Consumers and Health Systems
Budgetary and Operational Impacts
For health systems and consumers, even small price increases can have significant budgetary impacts, especially for chronic treatments. The integration of such medications into standard care protocols, as seen with GLP-1 agents, can alter the incidence of conditions and thus the demand for these drugs, potentially driving prices up further[3].
Access and Affordability
Efforts to improve transparency and affordability, such as the implementation of upper payment limits or drug affordability boards, could help manage the cost of prescription drugs. However, these measures are still in the experimental phase and have not been widely implemented or tested[2].
Key Takeaways
- Current Pricing: The current price per unit for Clindamycin-Benzoyl Peroxide (NDC: 45802-0507) is approximately $0.48506 per gram.
- Market Trends: The pharmaceutical market is experiencing a general inflation rate of 3.81% for 2025.
- Factors Influencing Pricing: Supply chain interactions, regulatory oversight, rebates, and discounts all impact the final cost of the drug.
- Price Projections: Short-term stability with potential small increases; long-term projections suggest gradual price increases due to inflation and market dynamics.
- Impact on Consumers and Health Systems: Even small price increases can have significant budgetary impacts, and efforts to improve transparency and affordability are ongoing.
FAQs
-
What is the current price of Clindamycin-Benzoyl Peroxide with NDC 45802-0507?
- The current price per unit is approximately $0.48506 per gram[1].
-
What is the projected drug price inflation rate for 2025?
- The projected overall drug price inflation rate for 2025 is 3.81% according to Vizient's summer 2024 Pharmacy Market Outlook[3].
-
How do rebates affect the final cost of prescription drugs?
- Rebates received by health insurers from manufacturers can reduce the net price paid by consumers and insurers, but the extent of these rebates can vary widely[2].
-
What regulatory measures are being considered to address high drug prices?
- Measures such as implementing upper payment limits and enhancing transparency across the pharmaceutical supply chain are being considered and tested in various states[2].
-
How do generic drug price increases impact the market?
- Generic drug price increases, such as the median 19.9% increase reported in 2022, can significantly affect the overall cost of healthcare and consumer budgets[2].
Sources
- Drug Price Trends for CLINDAMYCIN-BENZOYL PEROX - Drug Patent Watch
- Prescription Drug Price Transparency Results and Recommendations - Oregon Drug Price Transparency Program
- Vizient projects drug price inflation at 3.81% - Vizient, Inc.
- NDC 45802-736 Topical Gel clindamycin phosphate and benzoyl peroxide - FDA Report
